Skip to content
10-Q

Quarterly Report

Y-mAbs Therapeutics, Inc.

0001558370-25-010848

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 45.44M sh
Shares Diluted Q2 2025 · Jun 30, 2025 45.32M sh
Shares Diluted Q2 2025 · Jun 30, 2025 45.21M sh
Shares Diluted Q2 2025 · Jun 30, 2024 44.02M sh
Shares Diluted Q2 2025 · Jun 30, 2024 43.9M sh
Capex Q2 2025 · Jun 30, 2025 $127K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$5.26M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$3.18M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $62.29M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $67.23M
Stockholders Equity Q2 2025 · Jun 30, 2025 $87.49M
Stockholders Equity Q2 2025 · Mar 31, 2025 $89.46M
Stockholders Equity Q2 2025 · Dec 31, 2024 $92M
Stockholders Equity Q2 2025 · Jun 30, 2024 $95.34M
Stockholders Equity Q2 2025 · Mar 31, 2024 $99.19M
Stockholders Equity Q2 2025 · Dec 31, 2023 $100.99M
Current Liabilities Q2 2025 · Jun 30, 2025 $22.95M
Current Liabilities Q2 2025 · Dec 31, 2024 $23.7M
Total Liabilities Q2 2025 · Jun 30, 2025 $29.72M
Total Liabilities Q2 2025 · Dec 31, 2024 $27.9M
Current Assets Q2 2025 · Jun 30, 2025 $91.79M
Current Assets Q2 2025 · Dec 31, 2024 $98.51M
Total Assets Q2 2025 · Jun 30, 2025 $117.21M
Total Assets Q2 2025 · Dec 31, 2024 $119.9M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.07
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.19
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.21
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.36
Eps Basic Q2 2025 · Jun 30, 2025 −$0.07
Eps Basic Q2 2025 · Jun 30, 2025 −$0.19
Eps Basic Q2 2025 · Jun 30, 2024 −$0.21
Eps Basic Q2 2025 · Jun 30, 2024 −$0.36
Sga Expense Q2 2025 · Jun 30, 2025 $11.31M
Sga Expense Q2 2025 · Jun 30, 2025 $24.4M
Sga Expense Q2 2025 · Jun 30, 2024 $17.23M
Sga Expense Q2 2025 · Jun 30, 2024 $28.66M
Rd Expense Q2 2025 · Jun 30, 2025 $11.1M
Rd Expense Q2 2025 · Jun 30, 2025 $22.46M
Rd Expense Q2 2025 · Jun 30, 2024 $12.34M
Rd Expense Q2 2025 · Jun 30, 2024 $25.61M
Net Income Q2 2025 · Jun 30, 2025 −$3.24M
Net Income Q2 2025 · Jun 30, 2025 −$8.44M
Net Income Q2 2025 · Mar 31, 2025 −$5.2M
Net Income Q2 2025 · Jun 30, 2024 −$9.25M
Net Income Q2 2025 · Jun 30, 2024 −$15.88M
Net Income Q2 2025 · Mar 31, 2024 −$6.63M
Operating Income Q2 2025 · Jun 30, 2025 −$5.6M
Operating Income Q2 2025 · Jun 30, 2025 −$12.15M
Operating Income Q2 2025 · Jun 30, 2024 −$9.79M
Operating Income Q2 2025 · Jun 30, 2024 −$16.7M
Gross Profit Q2 2025 · Jun 30, 2025 $16.86M
Gross Profit Q2 2025 · Jun 30, 2025 $34.77M
Gross Profit Q2 2025 · Jun 30, 2024 $19.78M
Gross Profit Q2 2025 · Jun 30, 2024 $37.62M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $2.66M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.66M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $3.01M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $5.11M
Revenue Q2 2025 · Jun 30, 2025 $19.53M
Revenue Q2 2025 · Jun 30, 2025 $40.43M
Revenue Q2 2025 · Jun 30, 2024 $22.8M
Revenue Q2 2025 · Jun 30, 2024 $42.73M